Express Scripts Holding Company (NASDAQ:ESRX) VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total value of $40,103.91. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Express Scripts Holding Company (NASDAQ ESRX) traded up $0.22 on Friday, hitting $60.54. The stock had a trading volume of 2,640,000 shares, compared to its average volume of 4,230,000. The company has a market cap of $34,160.00, a price-to-earnings ratio of 8.82, a price-to-earnings-growth ratio of 0.89 and a beta of 0.88. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $77.50.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. The firm had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.74 EPS. research analysts forecast that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Express Scripts Holding by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock worth $2,652,964,000 after acquiring an additional 649,400 shares in the last quarter. Dodge & Cox increased its position in Express Scripts Holding by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after buying an additional 7,388,021 shares in the last quarter. State Street Corp increased its position in Express Scripts Holding by 1.1% during the 1st quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after buying an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its position in Express Scripts Holding by 4.2% during the 1st quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after buying an additional 704,218 shares in the last quarter. Finally, Macquarie Group Ltd. increased its position in Express Scripts Holding by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after buying an additional 922,406 shares in the last quarter. 88.55% of the stock is owned by hedge funds and other institutional investors.
A number of equities analysts recently issued reports on ESRX shares. Zacks Investment Research upgraded Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a report on Monday, October 16th. ValuEngine upgraded Express Scripts Holding from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Jefferies Group LLC set a $72.00 price objective on Express Scripts Holding and gave the company a “buy” rating in a report on Tuesday, August 29th. Needham & Company LLC started coverage on Express Scripts Holding in a report on Friday, July 21st. They set a “hold” rating for the company. Finally, Robert W. Baird restated a “hold” rating and set a $56.00 price objective on shares of Express Scripts Holding in a report on Friday, September 1st. Seven investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $69.53.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
What are top analysts saying about Express Scripts Holding Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts Holding Company and related companies.